Latest Version of Fujifilm's Synapse® RIS and TeleRIS Now Available Dose Management and Meaningful Use Incorporated into Version 6.1
CHICAGO, Nov. 27, 2011 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc. today announced the debut of version 6.1, the latest addition to the company's Synapse® RIS and Synapse® TeleRIS applications, at the Radiological Society of North America (RSNA) 2011 Annual Meeting. Version 6.1 includes graphical dashboards that provide end users with the ability to better monitor and manage performance in real time; Synapse® Financials for RIS, which provides a seamless option of incorporating practice management into the system; and advanced dose management features. By upgrading to this latest version, clinicians will enjoy an enhanced user experience and system performance.
"Higher productivity and ease of use are keys to a user's overall experience when it comes to the technology that they use on a daily basis, and Synapse Information Systems were designed specifically with their needs in mind," said Jim Morgan, Fujifilm's Vice President of Medical Informatics. "With version 6.1 end users can address Meaningful Use requirements and use improved tools to manage patient dose along with a new financial management optimization feature designed to improve facility operations."
New features of Synapse RIS 6.1 include:
Synapse Financials for RIS: Next generation practice management solution that incorporates powerful billing and management tools to improve cash flow and increase insurance reimbursements. Data is shared between the software modules to eliminate dual data entry.
Graphical Dashboards: This feature provides clinical information such as patient wait times, and patient volume. This information is provided in real-time allowing clinicians to address issues immediately, rather than waiting for a weekly or monthly report.
Dose Management: Going beyond simple dose capture, Synapse RIS 6.1 provides recommended exposure with equipment specific weighting, patient level dose estimates, and maximum recommended exposure.
As with Fujifilm's complete medical informatics product portfolio, version 6.1 for Synapse Information Systems is designed to also run in a virtualized environment which is proven to lower hardware acquisition/maintenance costs and reduce power consumption. It is expected to be available for delivery in the first quarter of 2012.
Hospitals and radiology groups around the country have selected Fujifilm and are currently deploying Synapse Information Systems. These facilities include Radiology Associates of Ocala, Fla., Valley Baptist Medical Center of Harlingen, Texas, the State of California and Western New York Radiology Associates, Buffalo, NY.
To learn more about Fujifilm's entire medical informatics portfolio, including Synapse® RIS and Synapse® TeleRIS, please visit rsna.fujimed.com or booth #4009 at RSNA 2011, November 27th - December 2nd at McCormick Place in Chicago, Illinois.
RSNA Booth # 4009, SOUTH BLG, HALL A
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women's health imaging systems, Fujifilm has products that are ideal for any size imaging environment. FUJINON is a subsidiary of FUJIFILM Medical Systems U.S.A., Inc., and supplies technologically advanced endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information visit www.fujimed.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and leading-edge products to a broad spectrum of industries, including electronic imaging, digital printing equipment, medical systems, life sciences, graphic arts, flat panel display materials, and office products, based on a vast portfolio of digital, optical, fine chemical and thin film coating technologies. The company was among the top 16 companies around the world granted U.S. patents in 2010, and in the year ended March 31, 2011, had global revenues of $25.8 billion****. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.
****At an exchange rate of 86 Yen to the dollar
© 2011 FUJIFILM Medical Systems U.S.A., Inc.
SOURCE FUJIFILM Medical Systems U.S.A., Inc.